Related Experiment Video
Updated: May 4, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
[Plasma cell leukemia: three case-reports and review of literature]
Hicham Eddou1, El Mehdi Mahtat1, Hamid Zahid2
1Service d'hématologie clinique, Hôpital militaire d'instruction Mohamed V Rabat, Maroc, Maroc.
Abstract:
Plasma cell leukemia (LP) is a rare hematologic malignancy. Its prognosis is very derogatory. It is defined by the presence in circulating blood of more than 2 G/L plasmocytes or greater than 20% of the total leukocytes. It comes in two forms: secondary plasma cell leukemia complicating multiple myeloma (MM) and primary setting. Its incidence is estimated at 0.9% of patients with acute leukemia and 2-4% of patients with MM. We report, through three observations, the clinical presentation of the plasma cell leukemia, its cytological features, immunophenotypic, physiopathological and therapeutic care.

